Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

BACKGROUND: Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Abdo, Mustafa, Watz, Henrik, Veith, Vera, Kirsten, Anne-Marie, Biller, Heike, Pedersen, Frauke, von Mutius, Erika, Kopp, Matthias V., Hansen, Gesine, Waschki, Benjamin, Rabe, Klaus F., Trinkmann, Frederik, Bahmer, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Letter to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7579879/
https://ncbi.nlm.nih.gov/pubmed/33087134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01543-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados